Ken Research Logo

Global peripheral vascular devices market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

The Global Peripheral Vascular Devices Market, valued at USD 10 billion, is expanding due to increasing PVD prevalence, technological innovations, and demand for minimally invasive treatments.

Region:Global

Author(s):Geetanshi

Product Code:KRAC4494

Pages:91

Published On:October 2025

About the Report

Base Year 2024

Global Peripheral Vascular Devices Market Overview

  • The Global Peripheral Vascular Devices Market is valued at USD 10 billion, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of peripheral vascular diseases, advancements in technology, and a growing geriatric population. The demand for minimally invasive procedures has also contributed significantly to the market's expansion, as healthcare providers seek to improve patient outcomes and reduce recovery times.
  • Key players in this market include the United States, Germany, and Japan, which dominate due to their advanced healthcare infrastructure, high investment in medical technology, and strong regulatory frameworks. The presence of leading manufacturers and a focus on research and development further enhance their market position, making these countries pivotal in the global peripheral vascular devices landscape.
  • The U.S. Food and Drug Administration (FDA) has implemented regulations aimed at enhancing the safety and efficacy of peripheral vascular devices. These regulations require manufacturers to conduct more rigorous clinical trials and post-market surveillance, ensuring that devices meet high safety standards before they can be marketed. This initiative is expected to improve patient safety and foster innovation in the industry.
Global Peripheral Vascular Devices Market Size

Global Peripheral Vascular Devices Market Segmentation

By Type:The market is segmented into various types of devices, including Peripheral Vascular Stents, Drug-Eluting Stents, Drug-Eluting Balloons, Bioresorbable Scaffolds, Angioplasty Balloons, Catheters, Guidewires, Filters, Access Devices, and Others. Among these, Peripheral Vascular Stents and Drug-Eluting Stents are leading the market due to their widespread use in treating peripheral arterial diseases. The increasing adoption of drug-eluting technologies is driven by their ability to reduce restenosis rates, making them a preferred choice for both healthcare providers and patients.

Global Peripheral Vascular Devices Market segmentation by Type.

By End-User:The end-user segmentation includes Hospitals, Ambulatory Surgical Centers/Outpatient Facilities, Cardiac Catheterization Labs, Specialty Clinics, and Home Healthcare. Hospitals are the dominant end-user segment, primarily due to the high volume of procedures performed and the availability of advanced medical technologies. The increasing number of outpatient procedures is also driving growth in Ambulatory Surgical Centers, as they offer cost-effective and efficient care.

Global Peripheral Vascular Devices Market segmentation by End-User.

Global Peripheral Vascular Devices Market Competitive Landscape

The Global Peripheral Vascular Devices Market is characterized by a dynamic mix of regional and international players. Leading participants such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Johnson & Johnson (including Cordis), Terumo Corporation, B. Braun Melsungen AG, Cook Medical Incorporated, Cardinal Health, Inc., Koninklijke Philips N.V. (Philips Healthcare), W. L. Gore & Associates, Inc. (Gore Medical), Merit Medical Systems, Inc., Siemens Healthineers AG, Stryker Corporation, Edwards Lifesciences Corporation, Asahi Intecc Co., Ltd., Becton, Dickinson and Company (BD), AngioDynamics, Inc., Teleflex Incorporated, iVascular S.L.U., Endologix LLC contribute to innovation, geographic expansion, and service delivery in this space.

Medtronic plc

1949

Dublin, Ireland

Boston Scientific Corporation

1979

Natick, Massachusetts, USA

Abbott Laboratories

1888

Abbott Park, Illinois, USA

Johnson & Johnson (Cordis)

1886

New Brunswick, New Jersey, USA

Terumo Corporation

1921

Tokyo, Japan

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Peripheral Vascular Devices Segment Revenue

Revenue Growth Rate (Peripheral Vascular Devices)

Market Share (Peripheral Vascular Devices)

Geographic Footprint (Number of Countries/Regions)

Product Portfolio Breadth (Number of SKUs/Device Types)

Global Peripheral Vascular Devices Market Industry Analysis

Growth Drivers

  • Increasing Prevalence of Peripheral Vascular Diseases:The prevalence of peripheral vascular diseases (PVD) is rising significantly, with an estimated 8.5 million adults in the U.S. affected, according to the CDC. This increase is attributed to factors such as diabetes and obesity, which are projected to affect over 30% of the adult population in future. The growing patient pool necessitates advanced treatment options, driving demand for peripheral vascular devices, which are essential for effective management and intervention.
  • Advancements in Medical Technology:The peripheral vascular devices market is experiencing rapid technological advancements, with innovations such as drug-eluting stents and bioresorbable scaffolds. In future, the global investment in medical technology is expected to reach $500 billion, enhancing the development of sophisticated devices. These advancements improve patient outcomes and reduce recovery times, making minimally invasive procedures more appealing, thus propelling market growth in the sector.
  • Rising Geriatric Population:The global geriatric population is projected to reach 1.5 billion in future, according to the World Health Organization. This demographic shift is significant as older adults are more susceptible to peripheral vascular diseases. The increasing need for effective treatment options for this age group is driving the demand for peripheral vascular devices, as healthcare systems adapt to cater to the unique needs of aging patients, ensuring better health outcomes.

Market Challenges

  • High Cost of Peripheral Vascular Devices:The high cost associated with peripheral vascular devices poses a significant challenge, with prices ranging from $1,000 to $30,000 depending on the device type and complexity. This financial burden can limit access for patients, particularly in low-income regions. As healthcare budgets tighten, hospitals may prioritize cost-effective alternatives, potentially hindering the growth of the peripheral vascular devices market.
  • Stringent Regulatory Requirements:Regulatory hurdles present a considerable challenge for manufacturers in the peripheral vascular devices market. In the U.S., the FDA requires extensive clinical trials and data submissions, which can take several years and cost millions. In future, the average time for device approval is expected to remain around 3-7 years, delaying market entry for innovative products and increasing the financial risk for companies investing in new technologies.

Global Peripheral Vascular Devices Market Future Outlook

The future of the peripheral vascular devices market appears promising, driven by technological advancements and an increasing focus on patient-centric care. As healthcare systems evolve, there will be a greater emphasis on minimally invasive procedures and home healthcare solutions. Additionally, the integration of digital health technologies is expected to enhance patient monitoring and engagement, further supporting the growth of this market. The ongoing investment in healthcare infrastructure will also play a crucial role in shaping future developments.

Market Opportunities

  • Expansion in Emerging Markets:Emerging markets present significant growth opportunities for peripheral vascular devices, with countries like India and Brazil experiencing rapid healthcare advancements. In future, healthcare spending in these regions is projected to increase by 10% annually, creating a demand for advanced medical devices and improving access to treatment options for peripheral vascular diseases.
  • Development of Innovative Products:The continuous development of innovative products, such as next-generation stents and advanced imaging technologies, offers substantial market opportunities. Companies investing in research and development can capitalize on the growing demand for effective and efficient treatment options, with the potential to capture significant market share as healthcare providers seek cutting-edge solutions to improve patient outcomes.

Scope of the Report

SegmentSub-Segments
By Type

Peripheral Vascular Stents

Drug-Eluting Stents

Drug-Eluting Balloons

Bioresorbable Scaffolds

Angioplasty Balloons

Catheters

Guidewires

Filters

Access Devices

Others

By End-User

Hospitals

Ambulatory Surgical Centers / Outpatient Facilities

Cardiac Catheterization Labs

Specialty Clinics

Home Healthcare

By Application

Peripheral Arterial Disease (PAD)

Target Artery Instability (TAI)

Access Artery Injury (AAI)

Arteriovenous Fistulas

Peripheral Aneurysms

Deep Vein Thrombosis

Varicose Veins

Others

By Distribution Channel

Direct Sales

Distributors

Online Sales

By Region

North America

Latin America

Western Europe

Eastern Europe

Balkan & Baltic Countries

Russia & Belarus

Central Asia

East Asia

South Asia & Pacific

Middle East & Africa

By Price Range

Low Price

Mid Price

High Price

By Product Lifecycle Stage

Introduction

Growth

Maturity

Decline

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., U.S. Food and Drug Administration, European Medicines Agency)

Manufacturers and Producers

Distributors and Retailers

Healthcare Providers and Hospitals

Medical Device Regulatory Consultants

Industry Associations (e.g., Medical Device Manufacturers Association)

Financial Institutions and Investment Banks

Players Mentioned in the Report:

Medtronic plc

Boston Scientific Corporation

Abbott Laboratories

Johnson & Johnson (including Cordis)

Terumo Corporation

B. Braun Melsungen AG

Cook Medical Incorporated

Cardinal Health, Inc.

Koninklijke Philips N.V. (Philips Healthcare)

W. L. Gore & Associates, Inc. (Gore Medical)

Merit Medical Systems, Inc.

Siemens Healthineers AG

Stryker Corporation

Edwards Lifesciences Corporation

Asahi Intecc Co., Ltd.

Becton, Dickinson and Company (BD)

AngioDynamics, Inc.

Teleflex Incorporated

iVascular S.L.U.

Endologix LLC

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Global Peripheral Vascular Devices Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Global Peripheral Vascular Devices Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Global Peripheral Vascular Devices Market Analysis

3.1 Growth Drivers

3.1.1 Increasing prevalence of peripheral vascular diseases
3.1.2 Advancements in medical technology
3.1.3 Rising geriatric population
3.1.4 Growing awareness and demand for minimally invasive procedures

3.2 Market Challenges

3.2.1 High cost of peripheral vascular devices
3.2.2 Stringent regulatory requirements
3.2.3 Lack of skilled professionals
3.2.4 Competition from alternative treatment options

3.3 Market Opportunities

3.3.1 Expansion in emerging markets
3.3.2 Development of innovative products
3.3.3 Strategic partnerships and collaborations
3.3.4 Increasing investment in healthcare infrastructure

3.4 Market Trends

3.4.1 Shift towards home healthcare solutions
3.4.2 Integration of digital health technologies
3.4.3 Focus on patient-centric care
3.4.4 Rise in telemedicine and remote monitoring

3.5 Government Regulation

3.5.1 FDA regulations on medical devices
3.5.2 CE marking requirements in Europe
3.5.3 Reimbursement policies for vascular procedures
3.5.4 Guidelines for clinical trials and studies

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Global Peripheral Vascular Devices Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Global Peripheral Vascular Devices Market Segmentation

8.1 By Type

8.1.1 Peripheral Vascular Stents
8.1.2 Drug-Eluting Stents
8.1.3 Drug-Eluting Balloons
8.1.4 Bioresorbable Scaffolds
8.1.5 Angioplasty Balloons
8.1.6 Catheters
8.1.7 Guidewires
8.1.8 Filters
8.1.9 Access Devices
8.1.10 Others

8.2 By End-User

8.2.1 Hospitals
8.2.2 Ambulatory Surgical Centers / Outpatient Facilities
8.2.3 Cardiac Catheterization Labs
8.2.4 Specialty Clinics
8.2.5 Home Healthcare

8.3 By Application

8.3.1 Peripheral Arterial Disease (PAD)
8.3.2 Target Artery Instability (TAI)
8.3.3 Access Artery Injury (AAI)
8.3.4 Arteriovenous Fistulas
8.3.5 Peripheral Aneurysms
8.3.6 Deep Vein Thrombosis
8.3.7 Varicose Veins
8.3.8 Others

8.4 By Distribution Channel

8.4.1 Direct Sales
8.4.2 Distributors
8.4.3 Online Sales

8.5 By Region

8.5.1 North America
8.5.2 Latin America
8.5.3 Western Europe
8.5.4 Eastern Europe
8.5.5 Balkan & Baltic Countries
8.5.6 Russia & Belarus
8.5.7 Central Asia
8.5.8 East Asia
8.5.9 South Asia & Pacific
8.5.10 Middle East & Africa

8.6 By Price Range

8.6.1 Low Price
8.6.2 Mid Price
8.6.3 High Price

8.7 By Product Lifecycle Stage

8.7.1 Introduction
8.7.2 Growth
8.7.3 Maturity
8.7.4 Decline

9. Global Peripheral Vascular Devices Market Competitive Analysis

9.1 Market Share of Key Players

9.2 KPIs for Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Peripheral Vascular Devices Segment Revenue
9.2.4 Revenue Growth Rate (Peripheral Vascular Devices)
9.2.5 Market Share (Peripheral Vascular Devices)
9.2.6 Geographic Footprint (Number of Countries/Regions)
9.2.7 Product Portfolio Breadth (Number of SKUs/Device Types)
9.2.8 R&D Intensity (% Revenue Spent on R&D)
9.2.9 Regulatory Approvals (Number of FDA/CE Approvals)
9.2.10 Product Innovation Rate (New Launches per Year)
9.2.11 Distribution Network Efficiency (Coverage, Speed, Reliability)
9.2.12 Pricing Strategy (Premium, Value, Competitive)
9.2.13 Brand Recognition (Global/Regional)
9.2.14 Customer Satisfaction Score (Net Promoter Score, Survey Data)

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Medtronic plc
9.5.2 Boston Scientific Corporation
9.5.3 Abbott Laboratories
9.5.4 Johnson & Johnson (including Cordis)
9.5.5 Terumo Corporation
9.5.6 B. Braun Melsungen AG
9.5.7 Cook Medical Incorporated
9.5.8 Cardinal Health, Inc.
9.5.9 Koninklijke Philips N.V. (Philips Healthcare)
9.5.10 W. L. Gore & Associates, Inc. (Gore Medical)
9.5.11 Merit Medical Systems, Inc.
9.5.12 Siemens Healthineers AG
9.5.13 Stryker Corporation
9.5.14 Edwards Lifesciences Corporation
9.5.15 Asahi Intecc Co., Ltd.
9.5.16 Becton, Dickinson and Company (BD)
9.5.17 AngioDynamics, Inc.
9.5.18 Teleflex Incorporated
9.5.19 iVascular S.L.U.
9.5.20 Endologix LLC

10. Global Peripheral Vascular Devices Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Government procurement policies
10.1.2 Budget allocation for healthcare
10.1.3 Evaluation criteria for suppliers

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in healthcare infrastructure
10.2.2 Spending on medical devices
10.2.3 Trends in corporate healthcare spending

10.3 Pain Point Analysis by End-User Category

10.3.1 Challenges faced by hospitals
10.3.2 Issues in ambulatory surgical centers
10.3.3 Needs of specialty clinics

10.4 User Readiness for Adoption

10.4.1 Awareness of new technologies
10.4.2 Training and education requirements
10.4.3 Financial readiness for investment

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of ROI post-implementation
10.5.2 Expansion of use cases in healthcare settings
10.5.3 Long-term benefits of device adoption

11. Global Peripheral Vascular Devices Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market gaps and opportunities

1.2 Business model components


2. Marketing and Positioning Recommendations

2.1 Branding strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban retail vs rural NGO tie-ups


4. Channel & Pricing Gaps

4.1 Underserved routes

4.2 Pricing bands


5. Unmet Demand & Latent Needs

5.1 Category gaps

5.2 Consumer segments


6. Customer Relationship

6.1 Loyalty programs

6.2 After-sales service


7. Value Proposition

7.1 Sustainability

7.2 Integrated supply chains


8. Key Activities

8.1 Regulatory compliance

8.2 Branding

8.3 Distribution setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product mix
9.1.2 Pricing band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target countries
9.2.2 Compliance roadmap

10. Entry Mode Assessment

10.1 JV

10.2 Greenfield

10.3 M&A

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven analysis

13.2 Long-term sustainability


14. Potential Partner List

14.1 Distributors

14.2 JVs

14.3 Acquisition targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone planning
15.2.2 Activity tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of industry reports from medical device associations and healthcare market research firms
  • Review of published articles and white papers on peripheral vascular devices from academic journals
  • Examination of regulatory filings and guidelines from health authorities such as the FDA and EMA

Primary Research

  • Interviews with vascular surgeons and interventional radiologists to gather insights on device usage
  • Surveys with hospital procurement managers to understand purchasing trends and preferences
  • Field interviews with medical device sales representatives to assess market dynamics and customer feedback

Validation & Triangulation

  • Cross-validation of data through multiple sources including trade publications and expert opinions
  • Triangulation of findings from primary interviews with secondary data trends
  • Sanity checks conducted through expert panel reviews comprising industry veterans

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of market size based on overall healthcare expenditure and device penetration rates
  • Segmentation of the market by product type, including stents, balloons, and catheters
  • Incorporation of demographic data to assess the impact of aging populations on device demand

Bottom-up Modeling

  • Collection of sales data from leading manufacturers of peripheral vascular devices
  • Estimation of market volume based on unit sales and average selling prices
  • Analysis of regional market dynamics to capture local variations in device adoption

Forecasting & Scenario Analysis

  • Multi-factor regression analysis incorporating factors such as technological advancements and healthcare policies
  • Scenario modeling based on potential market disruptions, including economic downturns and regulatory changes
  • Development of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Cardiovascular Device Usage120Vascular Surgeons, Interventional Cardiologists
Hospital Procurement Practices100Procurement Managers, Supply Chain Directors
Market Trends in Vascular Devices80Medical Device Sales Representatives, Product Managers
Patient Outcomes and Device Efficacy70Clinical Researchers, Healthcare Analysts
Regulatory Impact on Device Adoption60Regulatory Affairs Specialists, Compliance Officers

Frequently Asked Questions

What is the current value of the Global Peripheral Vascular Devices Market?

The Global Peripheral Vascular Devices Market is valued at approximately USD 10 billion, driven by the rising prevalence of peripheral vascular diseases, technological advancements, and an increasing geriatric population. This market is expected to grow further as demand for minimally invasive procedures rises.

What are the main types of peripheral vascular devices?

Who are the key players in the Global Peripheral Vascular Devices Market?

What factors are driving the growth of the peripheral vascular devices market?

Other Regional/Country Reports

Indonesia Peripheral Vascular Devices Market

Malaysia Peripheral Vascular Devices Market

KSA Peripheral Vascular Devices Market

APAC Peripheral Vascular Devices Market

SEA Peripheral Vascular Devices Market

Vietnam Peripheral Vascular Devices Market

Other Adjacent Reports

UAE Interventional Cardiology Devices Market

Saudi Arabia vascular access devices market report size, share, growth drivers, trends, opportunities & forecast 2025–2030UAE Atherectomy Devices MarketUAE Thrombectomy Devices Market

Qatar Embolization Devices Market

Qatar Vascular Closure Devices Market

UAE Endovascular Aneurysm Repair Market

Bahrain Cardiovascular Imaging Market

South Africa Diabetes Management Devices Market

Oman Wound Care Management Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022